Latest news

5 days 54 min ago
This week, the Labour Campaign for Drug Policy Reform (LCDPR) published a report on tackling drug-related harm. As the most common infection among people who inject drugs, hepatitis C is a major driver of health harms and inequalities in the UK. Following over a year of research and interviews with more than 700 people, the LCDPR recommended the following:
5 days 4 hours ago
The Infected Blood Inquiry is an independent inquiry, established by the UK government to look into a wide range of issues relating to infected blood, including how thousands of people came to be given blood containing hepatitis C, B and HIV prior to 1991. People infected include those in receipt of blood products, such as people treated for haemophilia, but also those who received ‘whole blood’ transfusions including after suffering injuries in accidents, requiring blood during routine operations and for women who had complications during childbirth.
3 weeks 2 days ago
According to media reports a drug consumption van organised by community activists began operating in Glasgow last week.
3 weeks 5 days ago
At the moment, when you call our helpline, you may not always hear the ‘ringback tone’ or ringing sound you normally hear when making a phone call. Please note that the phone is ringing, even if you cannot hear it. This is just happening temporarily because the calls are being transferred to our helpline team who are sometimes working remotely.
4 weeks 1 day ago
Northern Ireland Health Minister Robin Swann has announced an increase in support payments to those affected by the infected blood scandal, which saw patients infected with hepatitis C and HIV after receiving infected blood through the NHS prior to 1991. Annual payments will now range from £18,745 to just under £45,000, with the payment amount dependent on diagnosis. The announcement follows the announcement earlier this year of increased one-off payments, which the new change makes permanent. 
1 month 1 week ago
Following this morning's speech by Matt Hancock, Secretary of State for Health, on the future of public health the Chief Executive of The Hepatitis C Trust, Rachel Halford, made the following statement: “Public Health England performed a vital role in promoting and protecting the nation’s public health, carrying out a huge range of activity from monitoring drug-related deaths to cancer awareness campaigns.
1 month 2 weeks ago
A monitoring document published by Public Health England this week found that recent years have seen the highest prevalence of drug use in the past decade. The report, United Kingdom drug situation 2019: Focal Point annual report, also covers the drug market, drug-related deaths and drug-related harms (including a section on hepatitis C) for 2019. Key findings include:
2 months 3 days ago
Whilst coronavirus is keeping us apart physically, we were delighted to see so many people and organisations united in showing their support for hepatitis C elimination and World Hepatitis Day yesterday. Here's a quick roundup of some of the activities, announcements and articles from this year's World Hepatitis Day. NHS Tayside achieves world first elimination
2 months 4 days ago
Today (28th July), on World Hepatitis Day, politicians from across the political spectrum in England, Scotland and Wales have pledged their support to eliminating hepatitis C in the UK. As a blood-borne virus that can cause fatal cirrhosis and liver cancer if left untreated – and one that predominantly affects the most vulnerable people in our society – it is critical that now, more than ever, the UK takes sustained action to finally rid itself of this disease.
2 months 4 days ago
Guest blog by Philip Baldwin: I am always struck by the diversity of people diagnosed with hepatitis C. As a community of patients we are very varied and we can learn a lot from each other. I have attended several sessions of the Infected Blood Inquiry, where I heard powerful stories of people whose lives were impacted forever through blood transfusions or clotting agents. I was inspired by their bravery in confronting not just hepatitis C, but multiple institutional challenges and health inequalities.